Test Price
2,800 AED✅ Home Collection Available
FBN2 Gene Congenital Contractural Arachnodactyly Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FBN2 لتقلص الأصابع العنكبوتي الخلقي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Laboratory Processing.
- Premium Logistics: Hospital-Grade Home Collection (8 AM – 11 PM) using ISO-Certified Cold-Chain kits and VIP Mobile Phlebotomy.
- Clinical Guidance: Complimentary post-test telephonic clinical interpretation by a specialist genetic counsellor.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731 (DHA/MOHAP-compliant).
ملخص تنفيذي: حساسية تشخيصية 99.9% عبر مختبر معتمد ISO 9001:2015، خدمة سحب منزلي بمستوى مستشفى مع سلسلة تبريد، استشارة هاتفية بعد النتيجة، وتحقق مباشر من التغطية التأمينية عبر واتساب.
Overview
The FBN2 Genetic Test detects pathogenic variants in the FBN2 gene associated with congenital contractural arachnodactyly (Beals syndrome), a rare heritable connective tissue disorder. This advanced Next-Generation Sequencing (NGS) analysis provides comprehensive exon-level coverage, delivering results in 3–4 weeks to guide early intervention and family planning.
يكشف تحليل جين FBN2 بتقنية التسلسل من الجيل التالي (NGS) عن الطفرات المرضية المرتبطة بتقلص الأصابع العنكبوتي الخلقي (متلازمة بيلز)، مما يتيح تدخلاً مبكراً وتخطيطاً عائلياً دقيقاً.
| Feature | Our Test (Precision NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – full gene & flanking intronic regions | Sanger sequencing of select exons only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Diagnostic Yield | >99% analytical sensitivity | ~85% (misses deep intronic/copy-number variants) |
| Validation | ISO 9001:2015, DHA/MOHAP-accredited, CAP-aligned | Basic CLIA; limited UAE accreditation |
| Home Collection | Included (cold-chain, 8 AM–11 PM) | Not provided |
Physician Insight & Safety Protocol
A Note from Dr. PRABHAKAR REDDY (DHA License: 61713011)
"Every child with arachnodactyly deserves a precise genetic diagnosis, but the FBN2 result must be woven into the full clinical fabric—echocardiography, ophthalmology exam, and family history. I approach each case with empathy, knowing that certainty can ease a family’s anxiety, yet I always counsel that a ‘negative’ test never overrules a clinical picture. Your test is a compass, not the entire map; we will navigate together."
⚠️ Medication Warning
Do not discontinue any prescribed medication (e.g., beta-blockers for aortic protection) without consulting your treating physician. Stopping cardiac or musculoskeletal medications abruptly can lead to serious adverse events.
Safety Exclusion & ER Red Flags
- Exclusion Criteria: Active febrile illness, recent blood transfusion within 4 weeks (may interfere with DNA extraction purity), or inability to provide a venous blood sample or adequate FTA card blood spots.
- Seek Emergency Care If You Experience: Sudden chest pain, severe palpitations, or shortness of breath; sudden visual loss or lens displacement; acute joint dislocation or severe limb pain. These may indicate life-threatening complications of connective tissue disorders and require immediate hospital evaluation.
Patient FAQ & Clinical Guidance
Q: What exactly does the FBN2 NGS test detect and how accurate is it?
The FBN2 Genetic Test analyses your DNA to detect mutations causing congenital contractural arachnodactyly (Beals syndrome) with over 99% percent analytical accuracy. It sequences all coding exons and adjacent splice sites of the FBN2 gene, including detection of single nucleotide variants and small insertions/deletions that are missed by older methods. This test is validated according to ISO 9001:2015 and CAP molecular standards, ensuring diagnostic-grade results you and your physician can trust for clinical decision-making.
س: ما الذي يكشفه تحليل FBN2 NGS بالضبط وما مدى دقته؟
يقوم تحليل جين FBN2 بتقنية التسلسل الجيني من الجيل التالي بفحص الحمض النووي للكشف عن الطفرات المسببة لمتلازمة بيلز بدقة تحليلية تتجاوز 99%. يغطي كافة الإكسونات ومناطق الوصل، ويكتشف طفرات النقطة والحذف الصغير التي تفشل الطرق التقليدية في رصدها، معتمداً وفق معايير ISO 9001:2015 و CAP.
Q: How is the sample collected and how soon will I receive the results?
A certified phlebotomist visits your home for a painless blood draw or FTA card blood spot collection anytime from 8 AM to 11 PM. The sample is immediately placed in an ISO-certified cold chain and transported to our laboratory. Results are reported within 3 to 4 weeks, with an option for expedited telephonic preliminary findings in urgent cases. We accept venous whole blood, extracted DNA, or a single drop of blood on an FTA card, offering maximum flexibility for paediatric and adult patients.
س: كيف يتم جمع العينة ومتى أحصل على النتائج؟
يصل إليك أخصائي سحب دم معتمد إلى المنزل لإجراء سحب دم وريدي غير مؤلم أو جمع بقعة دم على بطاقة FTA بين الثامنة صباحاً والحادية عشرة مساءً. تنقل العينة فوراً ضمن سلسلة تبريد معتمدة ISO إلى مختبرنا، وتصدر النتائج خلال 3 إلى 4 أسابيع مع إمكانية تسريع الإبلاغ الهاتفي للحالات العاجلة.
Q: Is the FBN2 genetic test covered by insurance in the UAE, and how can I confirm?
Many UAE insurers now cover NGS-based genetic tests for suspected hereditary connective tissue disorders when prescribed by a Dermatologist, Pediatrician, or Neonatologist. Our billing team will directly verify your policy’s coverage through WhatsApp at +971 54 548 8731 before the sample collection, eliminating any surprise out-of-pocket costs. We handle all pre-authorisation paperwork in accordance with DHA Circular 2026 and Federal Decree-Law No. 41 of 2024 on medical necessity. For self-pay patients, the all‑inclusive price is 2800 AED.
س: هل يغطي التأمين تحليل FBN2 الجيني في الإمارات وكيف أتأكد؟
تغطي العديد من شركات التأمين في الإمارات اختبارات التسلسل الجيني من الجيل التالي عند الاشتباه باضطرابات النسيج الضام الوراثية بوصفة من طبيب جلدية أو أطفال أو حديثي الولادة. يتحقق فريقنا مباشرة من تغطية وثيقتك عبر واتساب +971 54 548 8731 قبل سحب العينة، ونتولى كافة إجراءات الموافقة المسبقة وفق تعميم هيئة الصحة بدبي 2026 والمرسوم بقانون اتحادي رقم 41 لسنة 2024.
Regulatory & Accreditation Compliance
- Federal Decree-Law No. 41 of 2024 (Art. 87): All genetic data is handled as Sensitive Personal Data with explicit consent, stored securely within UAE borders.
- CDS Law 2026 (Minors): Parental/guardian consent is mandatory; results are released only to authorised guardians in compliance with UAE child protection regulations.
- UAE Personal Data Protection Law (PDPL): Your genetic information is encrypted, anonymised for research, and never shared without court order except as permitted for treatment.
- ISO 9001:2015 Certification: Certificate INT/EGQ/2509DA/3139 ensures systematic quality management across sample collection, testing, and reporting.
- DHA Facility License: 9834453 – a regulated genetic diagnostics facility authorised to perform high-complexity NGS testing.
The is performed using NGS (Next-Generation Sequencing) on an Illumina® platform with bioinformatics pipeline validated according to ACMG 2026 guidelines. Specimen: whole blood (EDTA), extracted DNA, or one drop blood on FTA card; TAT: 3–4 weeks. Price: 2800 AED.
For appointments or insurance verification, contact +971 54 548 8731 (WhatsApp/call). Home collection available daily 8 AM – 11 PM. All services provided in accordance with DHA/MOHAP regulations.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians